Therapeutic targets for enterovirus infections
Authors:
- 30 June 2020
- journal article
- other
- Published by Taylor & Francis in Expert Opinion on Therapeutic Targets
- Vol. 24 (8) , 745-757
Abstract
Enteroviruses are among the most common viruses causing a huge number of acute and chronic infections leading to high economic costs. Novel nontoxic antivirals that reduce the virus load in acutely...Keywords
Funding Information
- Jane and Aatos Erkko Foundation
This publication has 137 references indexed in Scilit:
- Anti-Hepatitis C Virus Activity and Toxicity of Type III Phosphatidylinositol-4-Kinase Beta InhibitorsAntimicrobial Agents and Chemotherapy, 2012
- Single‐cell analysis of population context advances RNAi screening at multiple levelsMolecular Systems Biology, 2012
- Calcium signals and calpain-dependent necrosis are essential for release of coxsackievirus B from polarized intestinal epithelial cellsMolecular Biology of the Cell, 2011
- The Essential Role of Clathrin-mediated Endocytosis in the Infectious Entry of Human Enterovirus 71Journal of Biological Chemistry, 2011
- Comparative RNAi Screening Reveals Host Factors Involved in Enterovirus Infection of Polarized Endothelial MonolayersCell Host & Microbe, 2011
- Viral Reorganization of the Secretory Pathway Generates Distinct Organelles for RNA ReplicationCell, 2010
- In Vitro Antiviral Activity of V-073 against PoliovirusesAntimicrobial Agents and Chemotherapy, 2009
- Novel Antiviral Agent DTriP-22 Targets RNA-Dependent RNA Polymerase of Enterovirus 71Antimicrobial Agents and Chemotherapy, 2009
- Mutations in the Nonstructural Protein 3A Confer Resistance to the Novel Enterovirus Replication Inhibitor TTP-8307Antimicrobial Agents and Chemotherapy, 2009
- Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistanceGenes & Development, 2007